BETTEN-AID SIMPLE HEARTBURN RELIEF
  • Your heartburn meds are killing you!
    • Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID‐19: a meta‐analysis
    • Reflux Drugs Tied to Bone Fractures in Children
    • Heartburn drugs linked to fatal heart and kidney disease, stomach cancer
    • Millions of Canadians using acid-reflux drugs for too long, risking health side-effects
    • Using friendly bacteria to treat Irritable Bowel Syndrome
    • Proton Pump Inhibitors: How to Deprescribe These Nutrient Robbers
    • Pneumonia Risk with PPI Use Continues Past One Year, Researchers Say
    • Acidity and Heartburn Medications May Up Risk Of Pneumonia In The Elderly
    • Babies Given Antibiotics or Antacids May Be More Likely to Have Allergies, Study Finds
    • Study Links Popular Heartburn Drugs to Esophageal Cancer
    • The Purple Pill in the Red Zone
    • PPIs Linked to Pancreatic Cancer, Death
    • Guidelines for Limiting Unnecessary Use of Proton Pump Inhibitors
    • Superbug’ may depend on calcium to multiply
    • Some heartburn drugs linked with higher risk of death
    • Probiotics, Enzymes to Support Gut Health
    • Infants prescribed antacids for reflux have increased risk of bone fractures
    • How reflux drugs could raise fracture risk in babies
    • Heartburn Meds: Do They Do More Harm Than Good?
    • Day after Super Bowl, 16 million stay home on 'Super Sick Day'
    • Heartburn Medication Linked to Increased Risk of First Time Stroke
    • The Use Of Common Drugs For Heartburn Now Linked To Developing Stroke, Study Finds
    • Could common heartburn drugs increase stroke risk?
    • Stomach Flu More Common in PPI Users
    • Proton Pump Inhibitors May Reduce Efficacy of Capecitabine
    • Do This One Easy Thing If You Want Garbage In Your Cells
    • Proton Pump Inhibitor Lawsuits Mount
    • Study: PPI Acid Reflux Drugs Overused in People with GI Bleeds
    • PPI Heartburn Drugs Linked to Brain Problems, Fluid Build Up
    • Should you be taking stomach-acid reducers?
    • Dementia
    • Mental Health >
      • One-third of US adults may unknowingly use medications that can cause depression
      • Stomach acid drugs may cause depression
    • Heart Disease >
      • Giving PPIs and Antibiotics Together May Disrupt Heart Rhythm
      • Study Shows Heartburn Drugs Increase Risk of Cardiovascular Complications
    • Increased Infections >
      • AH-CHOO! THESE MEDS LINKED WITH HIGHER ALLERGY RISK IN KIDS
      • Acid Suppression Drugs Linked to Gastrointestinal Infections
      • PPIs increase risk for hepatic encephalopathy, spontaneous bacterial peritonitis
    • Kidney Failure >
      • ASN: PPIs associated with increased risk of kidney disease
      • Proton Pump Inhibitors May Increase Risk for Kidney Disease
      • Proton Pump Inhibitor Drugs Linked To Silent Kidney Damage
      • Popular OTC Acid Reflux Medicines May Carry Substantial Negative Side Effects, Studies Show
    • Osteoporosis >
      • New Concerns over Suspected Link Between Nexium and Osteoporosis
  • What is Betten-Aid?
    • Tummy Trouble Is On The Rise Among Americans, Gastrointestinal Experts Say
  • Store
  • A new Paradigm in Acid Reflux.
  • Natural vs. Synthetic
  • National group wants cancer warning labels on acid reflux drugs

Acid Suppression Drugs Linked to Gastrointestinal Infections

Picture
Commonly prescribed acid suppression medicines (ASMs) such as proton pump inhibitors (PPIs) and H2 receptor antagonists (H2RA) are linked with increased risk of bacterial intestinal infections, according to a new study.

Researchers at University College London, Ninewells Hospital, and other institutions conducted a population-based study involving 188,323 patients exposed to ASMs and 376,646 controls in Tayside (Scotland) between 1999 and 2013. The main outcome measure was a positive stool test for C. difficile, Campylobacter, Salmonella, Shigella, or E. coli O157.

The results included 22,705 positive test results - 15,273 for C. difficile, 6,590 for Campylobacter, 852 for Salmonella, 129 for Shigella, and 193 for E. coli O157; the results were not mutually exclusive. When compared with individuals in the community who did not take ASMs, those who did had a 1.7 to 3.7-times increased risks of C. difficile and Campylobacter gastrointestinal infections. Among hospitalized patients, those using the medications had 1.4-times to 4.5-times increased risks, respectively. The study was published on January 5, 2017, in the British Journal of Clinical Pharmacology.

“Although acid suppression therapy is often considered relatively free from side effects, the findings suggest that there are significant adverse gastrointestinal consequences of their use,” said senior author Professor Thomas MacDonald, PhD, of the NineWells medicines monitoring unit. “Users of these medications should be particularly vigilant about food hygiene, as the removal of stomach acid makes them more easily infected with agents such as Campylobacter, which is commonly found on poultry.”

Two groups of acid-suppressing medicines are available. A PPI is usually used first, as they tend to work better than H2 blockers. The aim of these drugs, however, is to be used for a month or so in order to settle acute symptoms. After this, it is common to reduce the dose to the lowest amount that prevents symptoms. PPIs include omeprazole, lansoprazole, pantoprazole, rabeprazole, and esomeprazole. H2 blockers include cimetidine, famotidine, nizatidine, and ranitidine.


Powered by Create your own unique website with customizable templates.